Vanda Pharmaceuticals | VNDA - Рыночная капитализация





Рыночная капитализация Изменить Дата
Acadia Pharmaceuticals USD 3.57B 221M 2026-05
Agios Pharmaceuticals USD 2.01B 423M 2026-03
Akebia Therapeutics USD 427M 297M 2025-12
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 9.7B 920M 2026-05
AstraZeneca USD 301.25B 13.1B 2026-03
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Eli Lilly USD 869.02B 146.97B 2026-03
Enanta Pharmaceuticals USD 122M 98M 2024-12
Esperion Therapeutics USD 885M 351M 2025-12
Halozyme Therapeutics USD 8.56B 905M 2026-05
Heron Therapeutics USD 238M 7M 2025-12
Insmed USD 15.56B 19.73B 2026-05
J&J USD 579.15B 78.91B 2026-03
Lexicon Pharmaceuticals USD 418M 73M 2025-12
Ligand Pharmaceuticals USD 3.72B 257M 2026-05
Merck USD 297.1B 35.84B 2026-03
Moderna USD 20.15B 8.53B 2026-03
Pfizer USD 147.4B 6.42B 2026-05
PTC Therapeutics USD 4.94B 698M 2026-05
Sanofi EUR 100.27B 605.48M 2026-03
Takeda JPY 8.33T 681.01B 2026-05
Teva Pharmaceutical Industries USD 34.27B 2.14B 2026-03
Ultragenyx Pharmaceutical USD 2.06B 1000K 2026-05
Vanda Pharmaceuticals USD 279M 6M 2024-12
Veracyte USD 2.59B 16M 2026-05